Announcements Trials

Browse Landscape

Phase

Phase 1/2 2 Phase NA 1 Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 805 Uterine Cervical Neoplasms 410 Fallopian Tube Neoplasms 289 Endometrial Neoplasms 287 Carcinoma, Ovarian Epithelial 252 Neoplasms 95 Recurrence 83 Breast Neoplasms 83 Peritoneal Neoplasms 66 Uterine Neoplasms 55 Colorectal Neoplasms 54 Uterine Cervical Dysplasia 50 Sarcoma 49 Vulvar Neoplasms 47 Neoplasm Metastasis 44 Carcinoma, Non-Small-Cell Lung 44 Stomach Neoplasms 42 Pancreatic Neoplasms 36 Melanoma 34 Testicular Neoplasms 32 Lung Neoplasms 32 Vaginal Neoplasms 28 Prostatic Neoplasms 28 Papillomavirus Infections 25 Carcinoma 25 Head and Neck Neoplasms 23 Esophageal Neoplasms 23 Carcinoma, Renal Cell 23 Urinary Bladder Neoplasms 21 Small Cell Lung Carcinoma 21

Interventions

artesunic acid 1 artenimol 1 artemisinin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Vulvar Diseases × Gynecologic × Clear all

NCT06075264 2025-08-14

ART-VIN IIB

Frantz Viral Therapeutics, LLC

Phase 2 Recruiting

Vulvar Diseases, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡